Geographic ancestry and markers of preterm birth

Expert Review of Molecular Diagnostics

Volumn 10, Issue 1, 2010, Pages 27-32

  Williams, Scott M ^a,b   Velez, Digna R ^a,b,c   Menon, Ramkumar ^a,b,d,e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Perinatal Research Center   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

Ancestry; Biomarker; Genetics of cytokine regulation; Preterm birth; Race

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

DIAGNOSTIC TEST; GENETIC ASSOCIATION; GENETIC VARIABILITY; GEOGRAPHY; INTERVENTION STUDY; PREGNANCY OUTCOME; PREMATURITY; REVIEW; RISK ASSESSMENT;

CONTINENTAL POPULATION GROUPS; FEMALE; GENETIC MARKERS; HUMANS; MALE; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS;

EID: 74749108445     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.09.70     Document Type: Review

References (44)

1. Martin JA, Kochanek KD, Strobino DM, Guyer B, MacDorman MF. Annual summary of vital statistics - 2003. Pediatrics 115, 619-634 (2005).
2. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 371, 75-84 (2008).
3. Goldenberg RL, Andrews WW. Intrauterine infection and why preterm prevention programs have failed. Am. J. Public Health 86, 781-783 (1996).
4. Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int. J. Epidemiol. 31, 1235-1239 (2002).
5. Barker DJ, Bagby SP. Developmental antecedents of cardiovascular disease: a historical perspective. J. Am. Soc. Nephrol. 16, 2537-2544 (2005).
6. Demissie K, Rhoads GG, Ananth CV et al. Trends in preterm birth and neonatal mortality among blacks and whites in the United States from 1989 to 1997. Am. J. Epidemiol. 154, 307-315 (2001).
7. Preterm Birth: Causes, Consequences and Prevention. Institute of Medicine, WA, USA (2006).
8. Berkowitz GS, Blackmore-Prince C, Lapinski RH, Savitz DA. Risk factors for preterm birth subtypes. Epidemiology 9, 279-285 (1998).
9. Moore JH, Williams SM. Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis. Bioessays 27, 637-646 (2005).
10. Lockwood CJ. Testing for risk of preterm delivery. Clin. Lab. Med. 23, 345-360 (2003).
11. Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study. BMJ 332, 937-939 (2006). (Pubitemid 44365549)
12. Menon R, Fortunato SJ, Thorsen P, Williams S. Genetic associations in preterm birth: a primer of marker selection, study design, and data analysis. J. Soc. Gynecol. Investig. 13, 531-541 (2006).
13. Lockwood CJ, Kuczynski E. Risk stratification and pathological mechanisms in preterm delivery. Paediatr. Perinat. Epidemiol. 15(Suppl. 2), 78-89 (2001).
14. Menon R, Thorsen P, Vogel I et al. Racial disparity in amniotic fluid concentrations of tumor necrosis factor (TNF)-a and soluble TNF receptors in spontaneous preterm birth. Am. J. Obstet. Gynecol. 198, 533; e1-e10 (2008)
15. Menon R, Williams SM, Fortunato SJ. Amniotic fluid interleukin-1b and interleukin-8 concentrations: racial disparity in preterm birth. Reprod. Sci. 14, 253-259. (2007).
16. Menon R, Merialdi M, Lombardi SJ, Fortunato SJ. Differences in the placental membrane cytokine response: a possible explanation for the racial disparity in preterm birth. Am. J. Reprod. Immunol. 56, 112-118 (2006).
17. Velez DR, Menon R, Thorsen P et al. Ethnic differences in interleukin 6 (IL-6) and IL6 receptor genes in spontaneous preterm birth and effects on amniotic fluid protein levels. Ann. Hum. Genet. 71, 586-600 (2007).
18. Romero R, Mazor M, Brandt F et al. Interleukin-1 α and interleukin-1 β in preterm and term human parturition. Am. J. Reprod. Immunol. 27, 117-123 (1992).
19. El Bastawissi AY, Williams MA, Riley DE, Hitti J, Krieger JN. Amniotic fluid interleukin-6 and preterm delivery: a review. Obstet. Gynecol. 95, 1056-1064 (2000).
20. Romero R, Yoon BH, Kenney JS, Gomez R, Allison AC, Sehgal PB. Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am. J. Reprod. Immunol. 30, 167-183 (1993).
21. Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant/ activating peptide-1/interleukin-8 in term and preterm parturition. Am. J. Obstet. Gynecol. 165, 813-820 (1991).
22. Rizzo G, Capponi A, Vlachopoulou A, Angelini E, Grassi C, Romanini C. The diagnostic value of interleukin-8 and fetal fibronectin concentrations in cervical secretions in patients with preterm labor and intact membranes. J. Perinat. Med. 25, 461-468 (1997). (Pubitemid 28014575)
23. Park JS, Park CW, Lockwood CJ, Norwitz ER. Role of cytokines in preterm labor and birth. Minerva Ginecol. 57, 349-366 (2005).
24. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am. J. Obstet. Gynecol. 166, 1576-1587 (1992).
25. Romero R, Tartakovsky B. The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am. J. Obstet. Gynecol. 167, 1041-1045 (1992).
26. Goldenberg RL, Goepfert AR, Ramsey PS. Biochemical markers for the prediction of preterm birth. Am. J. Obstet. Gynecol. 192, S36-S46 (2005).
27. Menon R, Velez DR, Morgan N, Lombardi SJ, Fortunato SJ, Williams SM. Genetic regulation of amniotic fluid TNF-α and soluble TNF receptor concentrations affected by race and preterm birth. Hum. Genet. 124, 243-253 (2008).
28. Ryckman KK, Williams SM, Krohn MA, Simhan HN. Genetic association of Toll-like receptor 4 with cervical cytokine concentrations during pregnancy. Genes Immun. 10(7), 636-640 (2009).
29. Simhan HN, Ryckman KK, Williams SM, Krohn MA. Genetic regulation of cervical antiinflammatory cytokine concentrations during pregnancy. Am. J. Obstet. Gynecol. 199, 163 (2008).
30. Ryckman KK, Williams SM, Krohn MA, Simhan HN. Racial differences in cervical cytokine concentrations between pregnant women with and without bacterial vaginosis. J. Reprod. Immunol. 78, 166-171 (2008).
31. Velez DR, Fortunato SJ, Williams SM, Menon R. Interleukin-6 (IL-6) and receptor (IL6-R) gene haplotypes associate with amniotic fluid protein concentrations in preterm birth. Hum. Mol. Genet. 17, 1619-1630 (2008).
32. Wang X, Zuckerman B, Pearson C et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287, 195-202 (2002).
33. Velez DR, Fortunato SJ, Morgan N et al. Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum. Reprod. 23, 1902-1909 (2008).
34. Smicun Y, Reierstad S, Wang FQ, Lee C, Fishman DA. S1P regulation of ovarian carcinoma invasiveness. Gynecol. Oncol. 103, 952-959 (2006).
35. Smicun Y, Gil O, Devine K, Fishman DA. S1P and LPA have an attachmentdependent regulatory effect on invasion of epithelial ovarian cancer cells. Gynecol. Oncol. 107, 298-309 (2007).
36. Oner C, Schatz F, Kizilay G et al. Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. J. Clin. Endocrinol. Metab. 93, 252-259 (2008).
37. Buhimschi IA, Buhimschi CS. Proteomics of the amniotic fluid in assessment of the placenta. Relevance for preterm birth. Placenta 29(Suppl. A), S95-S101 (2008).
38. Buhimschi IA, Zhao G, Rosenberg VA, Abdel-Razeq S, Thung S, Buhimschi CS. Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth. PLoS ONE 3, e2049 (2008).
39. Cobo T, Palacio M, Navarro-Sastre A et al. Predictive value of combined amniotic fluid proteomic biomarkers and interleukin-6 in preterm labor with intact membranes. Am. J. Obstet. Gynecol. 200, 499-1496 (2009).
40. Holst RM, Hagberg H, Wennerholm UB, Skogstrand K, Thorsen P, Jacobsson B. Prediction of spontaneous preterm delivery in women with preterm labor: analysis of multiple proteins in amniotic and cervical fluids. Obstet. Gynecol. 114, 268-277 (2009).
41. Moore JH, Williams SM. Epistasis and its implications for personal genetics. Am. J. Hum. Genet. 85, 309-320 (2009).
42. Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu. Rev. Med. 50, 249-261 (1999).
43. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann. Noninvasive Electrocardiol. 10, 88-101 (2005).
44. Pathak A, Curnier D, Fourcade J et al. QT dynamicity: a prognostic factor for sudden cardiac death in chronic heart failure. Eur. J. Heart Fail. 7, 269-275 (2005).